GlassScriptPhysician profile
Nelson Gn Kalil
NPI 1427074707
$72,476.16
in general payments reported to CMS, 2019-2025
99 companies · $6,224 in 2025
The $6,224 reported for 2025 was more than what 84% of Hematology & Oncology providers received nationally (typical 2025 total: $686).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $15K · 2020: $8,793 · 2021: $11K · 2022: $8,746 · 2023: $13K · 2024: $9,964 · 2025: $6,224.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $16K · Consulting Fee: $9,771 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $2,860 · Education: $188 · Long Term Medical Supply Or Device Loan: $167 · Travel and Lodging: $57.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $16,183.83 |
| Consulting Fee | $9,771.00 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $2,860.00 |
| Education | $187.86 |
| Long Term Medical Supply Or Device Loan | $166.66 |
| Travel and Lodging | $57.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Celgene Corporation | $9,380.99 | 2019-2025 | Reblozyl, Pomalyst, Opdualag |
| Abbvie INC. | $8,144.71 | 2019-2025 | |
| Pfizer INC. | $5,305.94 | 2019-2025 | |
| Astrazeneca Pharmaceuticals LP | $4,387.49 | 2019-2025 | Calquence, Imfinzi, Lynparza |
| Genzyme Corporation | $4,266.11 | 2019-2025 | |
| Novartis Pharmaceuticals Corporation | $4,232.19 | 2019-2025 | |
| Janssen Biotech, INC. | $3,900.75 | 2019-2025 | Darzalex, Rybrevant, Talvey |
| E.R. Squibb & Sons, L.L.C. | $3,813.50 | 2019-2025 | Opdivo, Opdualag, Augtyro |
| Ipsen Biopharmaceuticals, INC | $3,370.40 | 2019-2025 | Tazverik, Onivyde, Somatuline Depot |
| Janssen Scientific Affairs, LLC | $3,185.30 | 2019-2023 | Imbruvica |
| Exelixis INC. | $2,291.26 | 2019-2025 | Cabometyx |
| Merck Sharp & Dohme LLC | $1,198.05 | 2019-2025 | Keytruda, Welireg, Lynparza |
| Incyte Corporation | $1,047.66 | 2019-2025 | Jakafi, Monjuvi, Zynyz |
| Daiichi Sankyo INC. | $1,026.55 | 2019-2025 | Enhertu, Injectafer, Datroway |
| Takeda Pharmaceuticals U.S.A., INC. | $959.70 | 2019-2025 | Alunbrig, Fruzaqla, Iclusig |
Show all 99 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $901.09 | 2019-2025 | Kyprolis, Blincyto, Xgeva |
| Emd Serono, INC. | $779.00 | 2019-2025 | Bavencio |
| Genentech USA, INC. | $769.32 | 2019-2025 | Polivy, Lunsumio, Columvi |
| Pharmacyclics LLC, An Abbvie Company | $598.69 | 2019-2023 | Imbruvica, Epkinly |
| Seagen INC. | $556.95 | 2019-2023 | Adcetris, Padcev, Tivdak |
| Beigene, LTD. | $525.00 | 2021 | |
| Lilly USA, LLC | $473.55 | 2019-2025 | Jaypirca, Verzenio, Retevmo |
| Janssen Pharmaceuticals, INC | $466.06 | 2019-2024 | Xarelto |
| Adaptive Biotechnologies Corporation | $422.90 | 2022-2025 | Clonoseq |
| Pharmacosmos Therapeutics INC. | $416.76 | 2021-2025 | Monoferric, Cosela |
| Bayer Healthcare Pharmaceuticals INC. | $416.76 | 2019-2025 | |
| Regeneron Healthcare Solutions, INC. | $404.98 | 2019-2025 | Libtayo |
| Beigene USA, INC. | $390.98 | 2020-2025 | Brukinsa, Tevimbra |
| Eisai INC. | $385.40 | 2019-2025 | |
| Glaxosmithkline, LLC. | $360.29 | 2022-2025 | Ojjaara, Zejula, Jemperli |
| Boehringer Ingelheim Pharmaceuticals, INC. | $345.87 | 2019-2025 | |
| Karyopharm Therapeutics INC. | $322.96 | 2020-2025 | Xpovio |
| Mylan Institutional INC. | $308.87 | 2019-2023 | Ogivri |
| Astellas Pharma US INC | $288.55 | 2020-2025 | Padcev, Xtandi |
| Gilead Sciences, INC. | $287.78 | 2021-2025 | Trodelvy |
| Array Biopharma INC | $287.68 | 2020-2025 | Braftovi, Mektovi, Lorbrena |
| Acrotech Biopharma INC. | $275.82 | 2021-2025 | Beleodaq |
| Servier Pharmaceuticals LLC | $273.70 | 2021-2024 | |
| Kite Pharma, INC. | $266.47 | 2021-2025 | Yescarta |
| Celltrion USA INC. | $258.21 | 2023-2024 | Vegzelma |
| Taiho Oncology, INC. | $254.28 | 2019-2023 | |
| Rigel Pharmaceuticals, INC. | $251.14 | 2019-2024 | Rezlidhia, Tavalisse |
| Pharmaessentia USA Corporation | $249.50 | 2023-2025 | Besremi |
| Mirati Therapeutics, INC. | $232.49 | 2023-2024 | Krazati |
| Alnylam Pharmaceuticals INC. | $231.00 | 2023-2025 | Givlaari |
| Spectrum Pharmaceuticals INC. | $223.47 | 2023-2025 | Rolvedon |
| Puma Biotechnology, INC. | $217.30 | 2019-2025 | |
| Sobi, INC | $177.85 | 2022-2025 | |
| Coherus Oncology, INC. | $165.18 | 2021-2023 | |
| Agios Pharmaceuticals, INC. | $158.90 | 2019-2025 | Pyrukynd |
| Stemline Therapeutics INC. | $140.90 | 2023-2025 | Orserdu |
| G1 Therapeutics, INC. | $138.50 | 2022-2023 | Cosela |
| Alexion Pharmaceuticals, INC. | $137.83 | 2020-2024 | Ultomiris |
| Recordati_rare_diseases_inc. | $118.05 | 2023-2025 | Sylvant |
| Blueprint Medicines Corporation | $113.93 | 2020-2023 | Ayvakit |
| Myovant Sciences INC. | $113.79 | 2021 | |
| Genmab U.S., INC. | $110.94 | 2023-2025 | Epkinly |
| Beone Medicines USA, INC. | $110.81 | 2025 | Brukinsa, Tevimbra |
| Azurity Pharmaceuticals, INC. | $105.77 | 2024-2025 | Danziten, Vivimusta |
| Myriad Genetic Laboratories, INC. | $100.28 | 2020-2024 | Mychoice Cdx, Myrisk |
| Iovance Biotherapeutics, INC. | $84.28 | 2025 | Amtagvi |
| Eusa Pharma (US) LLC | $84.03 | 2020-2022 | |
| Tempus Ai, INC | $79.78 | 2024 | Xt Cdx |
| Bio Products Laboratory USA, INC. | $74.55 | 2019-2023 | Coagadex, Gammaplex |
| Epizyme, INC. | $73.88 | 2021 | |
| Clovis Oncology, INC. | $69.87 | 2019 | |
| Accord Healthcare, INC. | $66.64 | 2022 | |
| Partner Therapeutics, INC. | $64.06 | 2019-2023 | Leukine |
| Blue Earth Diagnostics | $63.11 | 2021-2022 | |
| Tersera Therapeutics LLC | $61.35 | 2021 | |
| Kyowa Kirin, INC. | $60.92 | 2023-2025 | Poteligeo |
| Lexicon Pharmaceuticals, INC. | $59.74 | 2019 | |
| Foundation Medicine, INC. | $59.38 | 2021-2022 | |
| Immunogen, INC. | $53.71 | 2023-2024 | Elahere, Elahere |
| Adc Therapeutics America, INC. | $52.36 | 2022 | |
| Syndax Pharmaceuticals, INC. | $51.14 | 2025 | |
| Deciphera Pharmaceuticals INC. | $48.29 | 2025 | Qinlock, Romvimza |
| Caris Mpi, INC. | $48.28 | 2025 | Mi Cancer Seek |
| Aveo Pharmaceuticals, INC. | $47.68 | 2024 | |
| Organon LLC | $47.22 | 2022-2025 | |
| Sanofi-Aventis U.S. LLC | $46.09 | 2021 | |
| Amneal Pharmaceuticals LLC | $45.34 | 2023 | Avastin |
| Day One Biopharmaceuticals | $44.80 | 2025 | Ojemda |
| Sun Pharmaceutical Industries INC. | $42.97 | 2019 | |
| Verastem, INC. | $36.49 | 2019-2020 | |
| Cti Biopharma Corp. | $35.99 | 2023 | Vonjo |
| Secura Bio, INC. | $35.96 | 2019-2022 | |
| Curium US LLC | $33.12 | 2020 | |
| Helsinn Therapeutics (U.S.), INC. | $32.13 | 2019-2025 | Akynzeo |
| Menarini Silicon Biosystems, INC. | $30.32 | 2025 | |
| Springworks Therapeutics, INC. | $29.24 | 2024 | Ogsiveo |
| Fresenius Kabi USA, LLC | $28.88 | 2024 | Stimufend |
| Tg Therapeutics, INC. | $24.12 | 2021 | |
| Acceleron Pharma, INC. | $24.11 | 2021 | |
| Tesaro, INC. | $20.91 | 2019 | |
| Novocure INC. | $19.94 | 2025 | Optune Lua (Novottf-200t) |
| Biocon Biologics INC | $18.42 | 2024 | Ogivri |
| Dova Pharmaceuticals | $17.49 | 2019 | |
| Amag Pharmaceuticals, INC. | $13.42 | 2021 |
Drugs and devices associated with these payments
Sarclisa $3,107Tazverik $2,942Braftovi $2,402Imbruvica $1,985Calquence $1,066Keytruda $554Darzalex $445Imfinzi $383Epkinly $379Padcev $348Venclexta $345Clonoseq $337Opdivo $323Enhertu $303Lynparza $291Pluvicto $291Inlyta $277Rybrevant $267Kisqali $259Xtandi $259Vegzelma $258Libtayo $256Besremi $250Onivyde $243Krazati $232Jakafi $232Talvey $231Givlaari $231Adcetris $224Rolvedon $223Talzenna $212Xpovio $210Monjuvi $208Polivy $205Monoferric $199Somatuline Depot $192Erleada $190Tecvayli $188Brukinsa $181Elahere $178Carvykti $175Reblozyl $172Mektovi $169Lorbrena $169Elrexfio $169Nubeqa $162Welireg $161Ojjaara $153Orserdu $141Cabometyx $139Yescarta $137Injectafer $133Lunsumio $132Zejula $128Xarelto $127Lenvima $122Lutathera $122Xofigo $122Jemperli $119Mekinist $119Sylvant $118Ibrance $118Bavencio $116Tibsovo $114Doptelet $111Tevimbra $106Beleodaq $102Kyprolis $101Fabhalta $88.09Tivdak $87.32Jaypirca $87.25Columvi $86.68Danziten $86.50Alunbrig $85.66Amtagvi $84.28Ultomiris $83.09Eliquis $82.54Piqray $82.22Bosulif $77.67Trodelvy $75.93Blincyto $72.98Paxlovid $72.79Cosela $70.85Pomalyst $70.27Rezlidhia $68.85Tavalisse $68.85Verzenio $68.04Opdualag $66.69Retevmo $65.52Lonsurf $64.85Inqovi $64.85Nplate $63.23Xgeva $63.23Jevtana $62.59Poteligeo $60.92Scemblix $60.32Keytruda Qlex $60.25Orgovyx $55.97Zynyz $55.25Datroway $54.71
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nelson Kalil listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.